Thomas Naoki Kakuda

12PUBLICATIONS
27CO-AUTHORS
Medical virologyMedical molecular engineering of nucleic acids and proteinsMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 10, 2026
Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model.

|Nov 05, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study.

Patrick T F Kennedy, Scott Fung, Maria Buti

|May 15, 2025
Population Pharmacokinetics of siRNA JNJ-73763989 in Healthy Participants and Patients With Chronic Hepatitis B.

Tetsuro Ogawa, Nele Goeyvaerts, Thomas N Kakuda

|Feb 26, 2025
Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B.

Florian van Bömmel, Thierry Verbinnen, Kosh Agarwal

|Feb 14, 2023
Pharmacokinetics of JNJ-73763989 and JNJ-56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment.

Thomas N Kakuda, Atef Halabi, Gernot Klein

|Jun 13, 2022
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B.

Ed Gane, Man-Fung Yuen, Thomas N Kakuda

Pageof 2

Frequent Collaborators

3 joint publications

Nele Goeyvaerts

3 joint publications

Michael Biermer

2 joint publications

Oliver Ackaert

1 joint publications

Matthew W McClure